S. Machtens

CXCR4/CXCL12 expression and signalling in kidney cancer

Andres Jan Schrader, Oskar Lechner, Markus F. Templin et al. · British Journal of Cancer · 2002 · 254 citations · Full text

Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients

E. Fricke, S. Machtens, Michael Hofmann et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 173 citations

Positron Emission Tomography, Urology, Engineering +8

Efficacy and Safety of TachoSil ® as Haemostatic Treatment versus Standard Suturing in Kidney Tumour Resection: A Randomised Prospective Study

Stefan Siemer, Sven Lahme, Stefan Altziebler et al. · European Urology · 2007 · 152 citations

Urology, Surgical Oncology, Renal Function +8

Expression of the p53 and maspin protein in primary prostate cancer: Correlation with clinical features

S. Machtens, J. Serth, Carsten Bokemeyer et al. · International Journal of Cancer · 2001 · 128 citations · Full text

Tumor Biology, Urology, Genitourinary Cancer +14

Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

Marc‐Oliver Grimm, Antoine G. van der Heijden, Marc Colombel et al. · European Urology · 2020 · 122 citations

Urological Research, Urology, Bcg Instillations +8